| Financial Year |
March 31 2023 |
| Monetary Funds |
12,071,734.14 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
629,210.00 |
| Accounts Receivable |
382,927,379.69 |
| Advances to Suppliers |
114,628,257.99 |
| Other Receivables |
24,609,640.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
499,357,171.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,192,527.02 |
| Total Current Assets |
1,058,666,711.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
983,965,762.04 |
| Investment Properties |
125,795,940.28 |
| Fixed Assetes |
994,526,553.18 |
| Under-construction Projects |
23,553,707.42 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
144,479,742.63 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
40,556,132.18 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
3,413,346,589.73 |
| Total Assets |
4,472,013,301.27 |
| Short-Term Loans |
705,767,001.08 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
262,826,104.75 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
59,288,069.25 |
| Taxes Payable |
141,516,759.99 |
| Interest Payable |
52,318,882.94 |
| Dividend Payable |
16,441,739.91 |
| Other payables |
124,997,029.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
188,892,755.90 |
| Other Current Liabilities |
9,292,794.84 |
| Sub-Total of Current Liabilities |
1,583,186,437.15 |
| Long-term Loans |
278,775,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
7,323,806.60 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
453,647.73 |
| Sub-Total of Non-Current Liabilities |
303,004,635.29 |
| Total Liabilities |
1,886,191,072.44 |
| Paid-In Capital(Or Share Stock) |
261,715,550.00 |
| Capital Surplus |
1,627,560,255.40 |
| Surplus Reserve |
88,283,589.63 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
535,939,506.53 |
| Minority Stockholder's Interest |
71,568,622.47 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,514,253,606.36 |
| Owner's Equity（Stockholder's Equity） |
2,585,822,228.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,472,013,301.27 |
